1. Home
  2. RH vs SRPT Comparison

RH vs SRPT Comparison

Compare RH & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

HOLD

Current Price

$166.81

Market Cap

2.3B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$20.69

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RH
SRPT
Founded
1979
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.5B
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
RH
SRPT
Price
$166.81
$20.69
Analyst Decision
Hold
Hold
Analyst Count
14
29
Target Price
$167.00
$25.85
AVG Volume (30 Days)
866.4K
3.6M
Earning Date
06-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
74.31
N/A
EPS
N/A
2.88
Revenue
$1,193,046,000.00
$2,198,237,000.00
Revenue This Year
$8.39
N/A
Revenue Next Year
$9.44
N/A
P/E Ratio
N/A
$7.02
Revenue Growth
24.52
15.58
52 Week Low
$106.30
$10.42
52 Week High
$256.78
$25.32

Technical Indicators

Market Signals
Indicator
RH
SRPT
Relative Strength Index (RSI) 60.98 69.95
Support Level $138.61 $20.61
Resistance Level $202.40 $23.54
Average True Range (ATR) 9.23 0.99
MACD 0.48 0.49
Stochastic Oscillator 82.96 95.38

Price Performance

Historical Comparison
RH
SRPT

About RH RH

RH is a luxury furniture and lifestyle retailer primarily operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories, including furniture, lighting, textiles, bath, decor, and is growing the presence of its hospitality business with 25 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: